GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » AS Latvijas Juras medicinas centrs (ORSE:LJM1R) » Definitions » Debt-to-Equity

AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Debt-to-Equity : 0.00 (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is AS Latvijas Juras medicinas centrs Debt-to-Equity?

AS Latvijas Juras medicinas centrs's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.00 Mil. AS Latvijas Juras medicinas centrs's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was €0.00 Mil. AS Latvijas Juras medicinas centrs's Total Stockholders Equity for the quarter that ended in Mar. 2024 was €6.30 Mil. AS Latvijas Juras medicinas centrs's debt to equity for the quarter that ended in Mar. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for AS Latvijas Juras medicinas centrs's Debt-to-Equity or its related term are showing as below:

ORSE:LJM1R's Debt-to-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 0.48
* Ranked among companies with meaningful Debt-to-Equity only.

AS Latvijas Juras medicinas centrs Debt-to-Equity Historical Data

The historical data trend for AS Latvijas Juras medicinas centrs's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AS Latvijas Juras medicinas centrs Debt-to-Equity Chart

AS Latvijas Juras medicinas centrs Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AS Latvijas Juras medicinas centrs Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Debt-to-Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of AS Latvijas Juras medicinas centrs's Debt-to-Equity

For the Medical Care Facilities subindustry, AS Latvijas Juras medicinas centrs's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


AS Latvijas Juras medicinas centrs's Debt-to-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, AS Latvijas Juras medicinas centrs's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where AS Latvijas Juras medicinas centrs's Debt-to-Equity falls into.



AS Latvijas Juras medicinas centrs Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

AS Latvijas Juras medicinas centrs's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

AS Latvijas Juras medicinas centrs's Debt to Equity Ratio for the quarter that ended in Mar. 2024 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AS Latvijas Juras medicinas centrs  (ORSE:LJM1R) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


AS Latvijas Juras medicinas centrs Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of AS Latvijas Juras medicinas centrs's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Business Description

Traded in Other Exchanges
N/A
Address
Patversmes iela 23, Riga, LVA, LV-1005
AS Latvijas Juras medicinas centrs is engaged in the provision of healthcare services. It operates hospitals and diagnostic centers. The company offers diagnostics services, magnetic resonance imaging, radiological diagnostics services, and ambulance services. It is also engaged in General medical practice activities, Special medical practice activities, Residential nursing care activities, Retail sale of medical and orthopedic goods in specialized stores, and Other personal service activities. The majority of the revenue is generated from the Ambulatory Medical Services.

AS Latvijas Juras medicinas centrs (ORSE:LJM1R) Headlines

No Headlines